Background: L-b-N-methylamino-L-alanine (BMAA) is a non-proteinic amino acid, that is neurotoxic in vitro and in animals, and is implicated in the causation of amyotrophic lateral sclerosis and parkinsonismdementia complex (ALS-PDC) on Guam. Given that natural amino acids can be N-nitrosated to form toxic alkylating agents and the structural similarity of BMAA to other amino acids, our hypothesis was that N-nitrosation of BMAA might result in a toxic alkylating agent, providing a novel mechanistic hypothesis for BMAA action. Findings: We have chemically nitrosated BMAA with sodium nitrite to produce nitrosated BMAA (N-BMAA) which was shown to react with the alkyl-trapping agent, 4-(p-nitrobenzyl)pyridine, cause DNA strand breaks in vitro and was toxic to the human neuroblastoma cell line SH-SY5Y under conditions in which BMAA itself was minimally toxic. Conclusions: Our results indicate that N-BMAA is an alkylating agent and toxin suggesting a plausible and previously unrecognised mechanism for the neurotoxic effects of BMAA.
Introduction
b-methylamino-L-alanine (BMAA) exposure has long been associated with neurodegenerative diseases, particularly on Guam where high rates of amyotrophic lateral sclerosis (ALS) and Parkinson's disease-like dementia complex (ALS-PDC) have been reported (Reed and Brody, 1975; Bradley and Mash, 2009 ). Such conditions have been linked to consumption of foodstuffs with high BMAA levels, typically flying foxes and other animals that bioaccumulate BMAA in their tissues as a result of eating cycad seeds (Bradley and Mash, 2009; Cox et al., 2003) . The increasing westernisation of the diet on Guam has decreased consumption of these BMAA rich dietary sources and this has been linked to decreases in the incidence of ALS and ALS-PDC on Guam (Plato et al., 2003) . These observations are consistent with BMAA being neurotoxic in humans. BMAA is present in cycad seeds through synthesis by symbiotic cyanobacteria. While numerous cyanobacteria species can produce BMAA (Cox et al., 2005) , it is currently unclear to what extent humans may be exposed e.g. via cyanobacterial blooms (Faassen, 2014) . However, BMAA has been found in the brains of ALS and other patients not only from Guam but also North America and this does suggest a more widespread exposure than initially considered (Murch et al., 2004a; Pablo et al., 2009) .
In vitro studies have shown that BMAA is toxic to neurons (Chiu et al., 2011; Lobner, 2009) . BMAA can react with bicarbonate ions to form a b-carbamate that is a structural analogue of glutamate and hence can bind to various glutamate receptors including the N-methyl-D-aspartate and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leading to excitotoxicity. Receptor activation leads to a chain of events that involves increased concentrations of intracellular Na + and Ca 2+ and decreased K + levels, altered membrane permeability, mitochondrial dysfunction and increased reactive oxygen species (ROS) production, and ultimately leads to cell death (Chiu et al., 2011; Lobner, 2009) . BMAA can also act as a substitute for L-serine and be incorporated into human (Dunlop et al., 2013) , though not bacterial proteins (van Onselen et al., 2015) nor proteins obtained from the brains of BMAA treated cynomologus monkeys (Spencer et al., 2016) . BMAA incorporated into proteins can cause protein misfolding and aggregation (Dunlop et al., 2013) a process often linked to neurodegenerative disease (Rodgers, 2014) . Furthermore, proteinbound BMAA may act as a reservoir that releases free BMAA as proteins are degraded (Murch et al., 2004b) . Numerous in vivo studies have shown that high dose acute and chronic BMAA exposure can have neurotoxic effects that are typically motor function deficits (Chiu et al., 2011; Karamyan and Speth, 2008; de Munck et al., 2013) . For example, a motor system disorder, similar to ALS/PDC was observed in macaques treated with between 0.1-0.3 g/BMAA/kg/day by gavage for up to 12 weeks (Spencer et al., 1987) . These doses may be much higher than would be observed in human populations (Duncan, 1992) , and so the association between BMAA and ALS/PDC remains controversial. In addition, the cycad nut also contains cycasin, whose active metabolite, methylazoxymethanol (MAM) is toxic to neurons and can affect brain development in experimental animal models (Kisby et al., 2009 (Kisby et al., , 2013 with DNA repair inhibition resulting in more pronounced effects suggesting a DNA damage mediated mechanism (Kisby et al., 2009 (Kisby et al., , 2013 . MAM is a methylating agent, one of a class of agents that is toxic, mutagenic and carcinogenic largely as a result of the formation of specific methylated nucleobase adducts (Kaina et al., 2007) . Interestingly DNA alkylating agents can also be formed by the N-nitrosation of natural amino acids (Garcia-Santos et al., 2001; Shephard et al., 1991) and hence may have similar properties to MAM.
Given the structural similarity of BMAA to other amino acids, our hypothesis was that N-nitrosation of BMAA might result in a toxic alkylating agent, providing a previously unrecognised mechanism for BMAA action.
Materials and methods

Materials
Unless otherwise stated, all materials, reagents and chemicals were purchased from Sigma-Aldrich (Gillingham, UK). Agarose, molecular grade crystalline powder was purchased from Bioline, UK, gel red nucleic acid stain from Biotium, UK and sodium hydroxide from Fisher Scientific, UK. SH-SY5Y, a human neuroblastoma cell line, was obtained from the Professor Doig (University of Manchester) at passage 10 and were cultured in Dulbecco's Modified Eagle's Medium (DMEM) with 10% (v/v) foetal bovine serum (FBS), 1% (w/v) glutamine, 10 mL/L of solution containing 10,000 U penicillin-G and 10 mg streptomycin/ml, and in a humidified incubator with gas mixture 95% air/5% CO2 (v/v) at 37 C. Cells were subcultured every 3-4 days when they had reached approximately 80% confluency and were discarded after passage 20. The plasmid nicking assay used a pUC8-based plasmid (pchAT 3319 bp) that was extracted from exponentially growing E. coli (strain DH5alpha). Amino acids were N-nitrosated by incubation with sodium nitrite (1 M) at 37 C for 1 h in sodium citrate buffer (pH2.1) either simultaneously with (Shephard et al., 1987) or immediately before the subsequent experimental procedure (Shephard et al., 1991) .
4-P-nitrobenzyl pyridine (NBP) trapping assay
The alkylating potency of BMAA, after nitrosation with sodium nitrite (nitrosated BMAA or N-BMAA) was assessed using the NBP trapping assay and presented as increases in absorbance at 595 nm.
Varying concentrations (20, 40, 60, 80 mM) BMAA or a-alanine (positive control), NaNO 2 (200 mM), NBP (24 mM), and citrate buffer (550 mM, pH 2.1) were incubated for 60 min at 37 C then a NaOH/acetonitrile colour development reagent (4 mL 1 M NaOH; 20 mL acetonitrile; 10.8 mL water) added to stop the alkylation reaction and basify the NBP-amino acid adducts to form a blue product. Immediately afterwards, absorbance measurements at 595 nm were obtained using a Tecan Genios microtitre plate reader. Negative controls were the nitrosation mix without the amino acid, the amino acids and nitrosation mix without the colour development reagent, the amino acids and the colour development reagent without the sodium nitrite and the amino acids without the nitrosation mix.
Plasmid nicking assay
The extent of DNA strand break formation following treatment with N-BMAA and BMAA was assessed using a plasmid nicking assay. N-BMAA & BMAA (1-7 mM) and phosphate buffer (pH 7.0) were incubated with 10 ng pchAT plasmid DNA for 3 h at 37 C. Post incubation, 8 mL of incubated plasmid mix was mixed with 2 mL of loading dye (10 mMTris HCl pH 7.5, 0.4% w/v orange G, 0.03% of w/v bromophenol blue, 0.03% w/v xylene cyanol FF, 15% Ficoll 400 and 50 mM EDTA) and loaded onto an agarose gel (1% w/v) prepared in TBE containing 5 mL of Gel Red. Gel electrophoresis was performed in TBE containing 50 mL/L Gel Red using at 100 mV for 30 min. Gels were scanned using a Typhoon Phosphorimager using the preset settings for Alexafluor Fluorescence. Image J software was used to quantify the supercoiled and the nicked bands and results expressed the fraction of plasmid that was nicked. Alanine and nitrosated alanine were similarly treated. The positive control was the plasmid treated with a Fenton's reaction mix containing FeSO 4 and H 2 O 2 in a Tris buffer and the negative controls the plasmid treated with or without nitrite.
Cellular toxicity
Cell toxicity of N-BMAA and BMAA was assessed in SH-SY5Y cells using a fluorimetric resazurin assay. SH-SY5Y cells were plated (10,000 per well) on 96-well plates and incubated for 24, 48, and 96 h after the addition of N-BMAA (as prepared for the acellular assays using NaNO 2 in citrate buffer) and BMAA (0.5-4 mM). After these periods, 0.005% (w/v) resazurin was added to the wells and the samples further incubated for 6 h. Sodium chloride [5M] was used as a positive control to induce cell death. The nitrosation mix (NaNO 2 /citrate) was used as the negative control.
Results and discussion
We first examined whether chemical nitrosation of BMAA with sodium nitrite resulted in the formation of an alkylating agent by using the NBP trapping assay (Shephard et al., 1987; Thomas et al., 1992; Gomez-Bomberelli et al., 2012) . We used conditions where the amino acid nitrosation and NBP alkylation were present simultaneously, in order to ensure the detection of labile intermediates (Shephard et al., 1987; Thomas et al., 1992) . NBP-adduct formation was dose-dependent and N-BMAA proved to be a more potent alkylating agent than nitrosated alanine, based upon the response obtained with similar amounts of amino acid present in the nitrosation mix (Fig. 1) . BMAA or alanine alone did not react with NBP (data not shown). The NBP assay has been widely used as a screening assay to detect the alkylating potency of many compounds (Garcia-Santos et al., 2001; Shephard et al., 1991 Shephard et al., , 1987 Thomas et al., 1992; Gomez-Bomberelli et al., 2012) , by the formation of adducts at the nucleophilic N4 position on NBP (Gomez-Bomberelli et al., 2012) . Since the N4 has similar physicochemical properties to the N7 of guanine, a favourable site of alkylation (Boysen et al., 2009) this provided the initial indication that N-nitrosated BMAA was likely to be a DNA damaging agent.
To further examine this, we used the plasmid nicking assay which is an extremely sensitive method for detecting DNA strand breakage (Dumax-Vorzet et al., 2015) . Incubation of increasing concentrations of BMAA following nitrosation with supercoiled plasmid DNA induced a linear increase in the amount of relaxed plasmid, demonstrating the formation of DNA single strand breaks (Fig. 2) . BMAA at the same concentrations also induced plasmid nicking but at lower levels ( Fig. 2 ) a result consistent with the observation that BMAA induced cellular DNA damage detectable by the alkaline comet assay (Chiu et al., 2012) . Incubation of N-alanine and alanine with plasmid DNA did not produce DNA nicks above those observed in controls under the conditions used. There was thus a clear difference between N-BMAA and N-alanine induced plasmid DNA strand break formation, in contrast to previous reports indicating that BMAA and alanine themselves were of similar toxicity in a number of cell lines: a result that was taken to indicate that BMAA did not contribute significantly to human neurodegenerative disease (Lee and McGeer, 2012) .
We finally examined whether N-BMAA is cytotoxic to SH-SY5Y cells. SH-SY5Y is an immortalised neuroblastoma cell line with many of the characteristics of neuronal cells. It is used commonly for investigations of BMAA induced neuronal toxicity and in other studies relating to AD, ALS, and ALS/PDC (Lopes et al., 2010; Kovalevich and Langford, 2013; Okle et al., 2013) . Under conditions in which BMAA showed minimal toxicity, N-BMAA was toxic (Fig. 3 ) and the differences were statistically significant at all time points (p < 0.05). N-BMAA toxicity was comparable to that of the positive control (5 M NaCl) and was maintained over the 96hr of the experiment except for the lowest doses for which toxicity appeared to accumulate over this time period.
We have not directly quantified the reactive alkylating species in this study and so do not know its level of formation from BMAA nitrosation. BMAA contains both a primary amine and a secondary amine that are potentially nitrosatable (Rostkowska et al., 1998) . Nitrosation of the secondary amine will lead to a nitrosamine that typically requires metabolic activation to be reactive (Hecht, 1994) whereas nitrosation of the primary amine results in a direct acting alkylating species that is the corresponding lactone (Garcia-Santos et al., 2001) . It is thus possible that the observed activity in vitro results from the nitrosation of the primary amine but we cannot rule out the involvement of a nitrosamine in the cellular toxicity. The biological potency of alkylating agents results in a large part from the formation of DNA adducts (Kaina et al., 2007; Drabløs et al., 2004) and hence it is likely that the cytotoxicity induced by nitrosated BMAA results from this mechanism although we cannot as yet rule out other mechanisms.
In summary, these results are consistent with our hypothesis that chemical nitrosation of BMAA to N-BMAA results in the formation of an alkylating agent. Furthermore, we have shown that N-BMAA is more toxic than BMAA itself. Previously, methylazoxymethanol (MAM), which is also present in the cycad nut (Kisby et al., 2009) , was shown to be a classical alkylating agent causing toxic DNA damage (e.g. O
6
-methylguanine) in target cells (Esclaire et al., 1999) resulting in changes in cell-signalling gene expression pathways associated with human neurodegenerative disease (Kisby et al., 2011) . The chemical structure of N-BMAA predicts that it will cause the same spectrum of DNA damage as that induced by MAM and other alkylating agents (Beranek et al., 1980) . Analogously, N-nitrosation of glycine results in both methylating and carboxymethylating agents that can Fig. 1 . Detection of alkylating intermediates formed by nitrosation of BMAA and Alanine using the NBP trapping assay. Varying concentrations of BMAA (^-^) or alanine (~-~) were simultaneously incubated with NaNO 2 , NBP, and citrate buffer, the colour development reagent added and absorbance measured at 595 nm. Absorbance of negative controls (see text) was less than 0.05. Fig. 2 . N-BMAA and BMAA in the plasmid nicking assay. N-BMAA, prepared by chemically nitrosating BMAA with NaNO 2 in citrate buffer, and BMAA were incubated with supercoiled pchAT plasmid DNA and the samples electrophoresed on an agarose gel containing GelRed fluoresecent DNA stain. Gels were scanned using a Typhoon Phosphorimager using Alexa fluorescence settings and ImageJ software was used to quantify the relative amounts of supercoiled and nicked plasmid. -methylguanine and O 6 -carboxymethylguanine respectively (Harrison et al., 1999) : both of these adducts have been detected in human DNA (Povey et al., 2000; Lewin et al., 2006) . In addition to dietary BMAA sources, BMAA may also be generated i n situ within the gastro-intestinal lumen as a result of cyanobacteria (Ley et al., 2006; Hill et al., 2014) which when coupled with heme-catalysed N-nitrosation (Lunn et al., 2007) may give rise to the formation of N-BMAA. These findings suggest a novel pathway of human exposure to potentially neurotoxic alkylating agents.
Conclusions
These results demonstrate that N-nitrosation of BMAA results in an alkylating agent that damages DNA in vitro, generating single strand breaks, and is toxic to neuroblastoma cells. Our results suggest a novel hypothesis in which in situ nitrosation of BMAA, and potentially other amines, likely catalysed by the microbiome leads to the formation of a variety of alkylating agents that may contribute to the aetiology of ALS and other neurodegenerative diseases.
